Azcuna, Luzviminda C.
HRN: 24-30-54 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/26/2023
01/01/2024
IV
4.5gm
Q6
Cap HR
Waiting Final Action
Indication: Empirical Escalation Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes